Applying Current Evidence on Tailored Therapeutic Strategies to Improve Outcomes for Patients With Myeloproliferative Neoplasms

In this on-demand webcast capturing a live CCO symposium, experts review best practices and emerging strategies for managing patients with myeloproliferative neoplasms, including essential thrombocythemia, myelofibrosis, and polycythemia vera.

Prithviraj Bose, MD Stephen Oh, MD, PhD Brady L. Stein, MD, MHS Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: April 21, 2022 Expired: April 20, 2023

Download this short summary slideset of key takeaway points on how experts approach the management of patients with myelofibrosis, polycythemia vera, and essential thrombocythemia.

Prithviraj Bose, MD Stephen Oh, MD, PhD Brady L. Stein, MD, MHS Released: March 2, 2022

Download this slideset for expert perspectives on best practices and emerging strategies in managing patients with myelofibrosis.

Stephen Oh, MD, PhD Released: February 23, 2022

Download this slideset for expert perspectives on best practices in managing patients with polycythemia vera.

Brady L. Stein, MD, MHS Released: February 23, 2022

Download this slideset for expert perspectives on best practices and emerging strategies for managing patients with essential thrombocythemia.

Prithviraj Bose, MD Released: February 23, 2022

In this commentary, experts address HCP questions on MPNs from a live webinar including treatment selection, novel therapeutics, and molecular testing.

Prithviraj Bose, MD
Program Director Stephen Oh, MD, PhD Brady L. Stein, MD, MHS Released: May 3, 2022